Status:
COMPLETED
Effect of Boussignac CPAP Ventilation on PaO2 and PaO2/FiO2 Ratio in Morbidly Obese Patients Undergoing Bariatric Surgery
Lead Sponsor:
Centro Hospitalar do Porto
Conditions:
Morbid Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if the application of Boussignac continuous positive airway pressure (CPAP) immediately after extubation improves PaO2 and PaO2/FiO2 ratio in morbidly obese p...
Detailed Description
Background: In 2010, the prevalence of obesity in individuals above 15 years old in Portugal was 15.5% for males and 17.7% for females. .In this country bariatric surgery has increased significantly p...
Eligibility Criteria
Inclusion
- Patients age between 18 and 65 years of age
- Morbidly obese with a body mass index \> 35 kg/m2
- Laparoscopic gastric bypass
Exclusion
- Patient refusal
- American Society of Anesthesiologists' (ASA) class IV
- Lung parenchyma disease
- Chronic Obstructive Pulmonary Disease
- Moderate to severe asthma
- Pre-existing cardiac failure (above class II in the New York Heart Association (NYHA) classification)
- Estimated pulmonary artery pressure ≥35mmHg
- Hemoglobin concentration (\[Hgb\]) less than 7 g / dL
- Need for invasive ventilation during preoperative immediate post-extubation defined in the preoperative period
- Patients with obstructive sleep apnea previously treated with CPAP
- Severe psychiatric disorder
- Language barrier
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT02297828
Start Date
October 1 2014
End Date
December 1 2014
Last Update
April 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Hospitalar Porto
Porto, Portugal, 4099-001